- Report
- May 2023
- 147 Pages
Global
From €4354EUR$4,949USD£3,778GBP
- Report
- May 2023
- 147 Pages
Global
From €4354EUR$4,949USD£3,778GBP
- Report
- March 2023
- 107 Pages
Global
From €3166EUR$3,599USD£2,747GBP
- Report
- April 2024
- 140 Pages
Global
From €4354EUR$4,949USD£3,778GBP
- Report
- October 2023
- 180 Pages
Global
From €1100EUR$1,250USD£954GBP
€2199EUR$2,500USD£1,908GBP
- Report
- July 2024
- 90 Pages
China
From €1583EUR$1,800USD£1,374GBP
- Report
- January 2024
- 250 Pages
Global
€4394EUR$4,995USD£3,813GBP
- Report
- September 2023
- 114 Pages
Global
From €2595EUR$2,950USD£2,252GBP
- Report
- September 2023
- 194 Pages
Global
From €4355EUR$4,950USD£3,778GBP
- Report
- September 2023
- 89 Pages
From €2595EUR$2,950USD£2,252GBP
- Report
- September 2023
- 101 Pages
North America
From €2595EUR$2,950USD£2,252GBP
- Report
- September 2023
- 112 Pages
Europe
From €3035EUR$3,450USD£2,633GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3035EUR$3,450USD£2,633GBP
- Report
- November 2022
- 160 Pages
Global
€2991EUR$3,400USD£2,595GBP
- Report
- September 2022
- 95 Pages
Global
From €3739EUR$4,250USD£3,244GBP
- Report
- April 2020
- 165 Pages
Global
From €1223EUR$1,390USD£1,061GBP
- Drug Pipelines
- January 2018
- 16 Pages
Global
From €8797EUR$10,000USD£7,633GBP
- Report
- August 2025
- 105 Pages
Global
From €3500EUR$4,262USD£3,143GBP
- Report
- October 2024
- 85 Pages
Global
From €3500EUR$4,262USD£3,143GBP
- Report
- October 2024
- 92 Pages
Global
From €3500EUR$4,262USD£3,143GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more